Perbedaan Organon Pharma Indonesia Tbk. dan Bank Woori Saudara Indonesia 1906 Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Bank Woori Saudara Indonesia 1906 Tbk. diperdagangkan di Rp214 (kapitalisasi pasar 3,11 T, volume 24 jam 1,92 jt). Perbedaan utamanya: Bank Woori Saudara Indonesia 1906 Tbk. jauh lebih besar — sekitar 29,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SDRA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 3,11 T |
Volume | — | 1,92 jt |
Lot | — | 19,18 rb |
Perputaran | — | 406,26 jt |
Harga Rata-rata | — | 211,83 |
Nilai Transaksi | — | 406,26 jt |
Harga Ekuilibrium Indikatif | — | 214 |
Volume Ekuilibrium Indikatif | — | 5 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Bank Woori Saudara Indonesia 1906 Tbk(the Bank)(formerly PT Bank Himpunan Saudara 1906) was established under its original name of Perkumpulan Himpunan Saudara on 1906 then at 11 Nov 1955 the Company has been licensed as Saving Bank. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Meiyane, S.H., dated Apr 26, 2006, concerning company public offering. On December 24, 2014 the Extraordinary Shareholders Meeting Approved the change of name into PT Bank Woori Saudara Indonesia 1906 Tbk.
Selengkapnya di halaman SDRA →